A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI Andy WolffRevan Kumar JoshiColin Dawes Systematic Review Open access 16 November 2016 Pages: 1 - 28
Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials André Vicente Esteves de CarvalhoRodrigo Pereira DuquiaRenan Rangel Bonamigo Review Article Open access 12 November 2016 Pages: 29 - 51
Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects Adrian L. Lopresti Review Article Open access 25 November 2016 Pages: 53 - 64
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease Rebecca J. GrykaLeo F. BuckleySarah M. Anderson Review Article Open access 06 January 2017 Pages: 65 - 72
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies Kyle John WilbyZiad Ghantous NasrAnas Hamad Review Article Open access 18 January 2017 Pages: 73 - 78
Drug Exposure and the Risk of Microscopic Colitis: A Critical Update Alfredo J. Lucendo Current Opinion Open access 18 January 2017 Pages: 79 - 89
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management Nuno VicenteLuís CardosoFrancisco Carrilho Therapy in Practice Open access 19 January 2017 Pages: 91 - 96
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report Atsushi TanakaTsukasa NakamuraKoichi Node Therapy in Practice Open access 10 January 2017 Pages: 97 - 101
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study Frank R. ErnstWalter SandulliMaryKate Lavan Original Research Article Open access 09 December 2016 Pages: 103 - 115
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study Laura W. LeicherJacques C. de GraafJan Willem B. de Groot Original Research Article Open access 15 November 2016 Pages: 117 - 124
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice Mihail BoyanovAlexander ShinkovReneta Petkova Original Research Article Open access 17 December 2016 Pages: 125 - 132
Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan Sachie KubotaKazuyuki SaitoYasuo Kodama Original Research Article Open access 19 December 2016 Pages: 133 - 143
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome Shuying YangTeodora Pene Dumitrescu Original Research Article Open access 21 December 2016 Pages: 145 - 158
Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model Steven M. BrunelliScott P. SibbelGlenn M. Chertow Original Research Article Open access 11 January 2017 Pages: 159 - 166
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates Christine M. SanfilippoCatherine M. AllaireHeleen H. DeCory Original Research Article Open access 11 January 2017 Pages: 167 - 175
Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen Hideo KatoMao HagiharaHiroshige Mikamo Original Research Article Open access 06 January 2017 Pages: 177 - 187
Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method Maryam BazarganDavid J. R. FosterBeverly S. Muhlhausler Original Research Article Open access 10 January 2017 Pages: 189 - 198
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data Remington L. NevinJeannie-Marie Leoutsakos Original Research Article Open access 06 January 2017 Pages: 199 - 210
Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project Beatrice J. EdwardsDennis W. RaischDennis P. West Original Research Article Open access 06 January 2017 Pages: 211 - 218
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System Nasir IdkaidekTawfiq ArafatIbrahim Al-Adham Original Research Article Open access 10 January 2017 Pages: 219 - 224
Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients José Antonio Mata-MarínAriane Estrella Weiser SmekeJesús Gaytán-Martínez Original Research Article Open access 25 January 2017 Pages: 225 - 231
Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events Hiroki WakabayashiHitoshi InadaAkihiro Sudo short communication Open access 26 December 2016 Pages: 233 - 239
Comment on: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects” Nuggehally R. Srinivas Commentary Open access 30 November 2016 Pages: 241 - 242
Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects” Meng-Kwoon SimKok-Onn Lee Reply Open access 30 November 2016 Pages: 243 - 244
